Drugs / CombiflexOmega peri
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01533298 | Jul → Dec 2011 | — | JW Life Science | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CombiflexOmega peri | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01533298 ↗ |
| Route | Intravenous | “intravenously over 3 days infusion” NCT01533298 ↗ |